申请人:Dupont Pharmaceuticals Company
公开号:US06159980A1
公开(公告)日:2000-12-12
Corticotropin releasing factor (CRF) antagonists of Formula (I) ##STR1## and their use in treating psychiatric disorders and neurological diseases including major depression, anxiety-related disorders, post-traumatic stress disorders, supranuclear palsy and eating disorders.
促肾上腺皮质激素释放因子(CRF)拮抗剂的化学式(I)##STR1## 及其在治疗精神障碍和神经系统疾病中的应用,包括重性抑郁症、焦虑相关障碍、创伤后应激障碍、上核性麻痹和进食障碍。